查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1401805

基因治疗市场，按载体类型、按基因类型、按治疗、按应用、按国家和地区 - 2023-2030 年行业分析、市场规模、市场份额和预测

Gene Therapy Market, By Vector Type, By Gene Type, By Therapy, By Application, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030
出版日期: | 出版商: AnalystView Market Insights | 英文 301 Pages | 商品交期: 2-3个工作天内

价格

报告要点

2022 年基因治疗市场规模达 83 亿美元，2023 年至 2030 年复合CAGR为 22.3%。

基因治疗市场-市场动态

全球癌症、罕见疾病遗传性疾病等慢性疾病盛行率的增加预计将推动基因治疗市场的成长。

基因疗法透过专门针对导致癌症进展的潜在遗传异常，提供了一种有前景的抗癌策略。根据世界卫生组织的数据，2020 年全球约有 1,810 万癌症病例，其中男性 930 万，女性 880 万人。虽然基因疗法主要着重于解决缺乏有效传统治疗方案的罕见遗传性疾病，但国家生物技术资讯中心估计，每年有495,000 名婴儿出生时患有先天性畸形，其中39 万名婴儿患有G6PD 缺乏症，21,400名婴儿患有唐氏症，9,000 名婴儿患有β - 地中海贫血、5,200 名镰状细胞疾病患者和 9,760 名氨基酸失调患者。透过根据个人的特定基因谱量身定制治疗，基因治疗可以实现更个人化的医疗保健方法。此外，增加基因治疗研究和开发的投资和资助可以为市场成长创造机会。然而，与基因疗法相关的巨额成本在报销和可及性方面提出了挑战。

基因治疗市场-关键见解

根据我们的研究分析师分享的分析，预计全球基因治疗市场在预测期内（2023-2030）每年将以 22.3% 左右的CAGR成长

根据载体类型细分，预计非病毒载体将在 2022 年显示最大的市场份额

根据基因类型细分，抗原类型是2022年的主导类型

从治疗细分来看，2022年体内治疗为主导类型

根据应用细分，肿瘤疾病是 2022 年的主导类型

按地区划分，北美是 2022 年的主要收入来源

基因治疗市场-細項分析：

全球基因治疗市场根据载体类型、基因类型、治疗、应用和区域进行细分。

根据载体类型将市场分为三类：病毒载体和非病毒载体。该市场主要由非病毒载体主导。一般来说，与病毒载体相比，非病毒载体表现出优越的安全性，从而最大限度地减少免疫反应或意外副作用的机会。此外，非病毒载体能够容纳更大的DNA有效负载，从而能够递送更广泛的遗传物质。

市场依基因类型分为两类：抗原、细胞激素、肿瘤抑制因子、自杀因子、缺乏因子、生长因子、受体和其他。抗原部分主导市场。基因治疗在增强免疫系统识别和攻击与疾病相关的特定抗原的能力方面发挥着重要作用。

根据治疗，市场分为三类：体内治疗和体外治疗。体内疗法在市场上占据主导地位。体内疗法在市场上占有重要地位。研究人员正在积极研究各种疾病的体内基因疗法，例如遗传性疾病、特定形式的癌症和其他医疗状况。目的是修改患者的遗传物质以提供治疗优势。

市场依应用分为三类：肿瘤疾病、罕见疾病、神经疾病和其他疾病。该市场主要由肿瘤疾病领域主导。几种针对肿瘤疾病的基因疗法目前正在进行不同阶段的临床试验。某些疗法已获得特定适应症的监管批准，而其他疗法仍处于研究阶段。

基因治疗市场-地理洞察

从地理来看，这个市场遍及北美、拉丁美洲、欧洲、亚太地区、中东和非洲。这些区域根据业务涉及的国家进一步划分。由于其高度先进的医院基础设施以及对细胞和基因治疗不断增长的需求，预计北美地区将主导市场的成长。北美拥有强大的医疗保健生态系统，其特点是学术界、工业界和医疗保健提供者之间的合作。这种协作环境促进创新并加速将科学发现转化为临床应用。根据美国医院资讯科技协会的数据，2018 年，98.3% 的医院采用了电子健康记录 (EHR)，并且根据关键访问医院 (CAH) 状态没有差异。此外，58.7% 和 55.6% 的医院分别采用了先进的病患参与 (PE) 和临床文件架构 (CDA) 功能。人们越来越认识到细胞和基因疗法在治疗各种疾病（包括癌症和遗传性疾病）方面的潜力，导致对这些疗法的需求增加。截至2022 年12 月，美国食品药物管理局(FDA) 已批准四种基因疗法在美国(US) 销售：2017 年批准的Luxterna (voretigene neparvovec)、2019 年批准的Zolgensma (onasemnogene abeparvovec-xioi)、 Tecartus (brexucabtagene autoleucel) 于 2020 年获得批准，Hemgenix (etranacogen dezaparvovec) 于 2022 年获得批准。虽然仍处于早期阶段，但基因疗法具有治疗和治愈以前被认为无法治疗的疾病的潜力。预计欧洲将在未来几年成为第二大基因治疗市场，这主要是由于对个人化基因治疗的需求不断增长。

基因治疗市场-竞争格局：

基因治疗市场正在经历显着成长，针对各种适应症正在开发多种疗法。这呈现出一个竞争格局，需要彻底的分析，以确定基因治疗开发商的机会和挑战。在製药业，细胞和基因疗法的出现带来了创新的治疗方法，公司专注于专利并进行策略性投资以引进先进技术。这些投资不仅增强了专利组合，而且使关键参与者处于行业进步的最前沿。最近的交易凸显了细胞和基因疗法在製药领域的重要性，战略合作伙伴关係、专利和就业趋势发生了动态变化。美国在全球采用方面处于领先地位，其协作努力、变革性专利和不断变化的就业机会塑造了创新进步的未来。随着越来越多的基因疗法进入市场，公司必须有效地准备其产品和上市策略，以履行其改变患者生活的承诺。这些公司必须以最大限度提高患者利益的方式推出产品，同时确保在市场上取得成功。

最近的发展：

2021年12月22日，诺华宣布签订最终协议，收购英国眼部基因治疗公司Gyrscope Therapeutics的全部已发行股本。地理萎缩是干性老年黄斑部病变的一种高级形式，会导致高级且不可逆的思维丧失1。

目录

第一章：基因治疗市场概述

  • 研究范围
  • 市场预估年份

第 2 章：执行摘要

  • 市场片段
    • 按载体类型分類的基因治疗市场片段
    • 按基因类型分類的基因治疗市场片段
    • 基因治疗市场片段（按疗法）
    • 基因治疗市场片段（按应用）
    • 按国家/地区分類的基因治疗市场片段
    • 按地区分類的基因治疗市场片段
  • 竞争洞察

第 3 章：基因治疗主要市场趋势

  • 基因治疗市场驱动因素
    • 市场驱动因素的影响分析
  • 基因治疗市场限制
    • 市场限制影响分析
  • 基因治疗市场机会
  • 基因治疗市场未来趋势

第 4 章：基因治疗产业研究

  • PEST分析
  • 波特五力分析
  • 成长前景图
  • 规范架构分析

第 5 章：基因治疗市场：COVID-19 影响分析

  • COVID-19 之前的影响分析
  • COVID-19 后影响分析
    • 表现最佳的市场区隔
    • 边际增长部分
    • 最鬆散的部分
    • 边际损失部分

第 6 章：基因治疗市场格局

  • 2022 年基因治疗市场占有率分析
  • 按主要製造商分類的故障数据
    • 既定玩家分析
    • 新兴玩家分析

第 7 章：基因治疗市场 - 按载体类型

  • 概述
    • 按向量类型分類的细分市场占有率分析
    • 病毒载体
    • 非病毒载体

第 8 章：基因治疗市场 - 按基因类型

  • 概述
    • 按基因类型分類的细分市场占有率分析
    • 抗原
    • 细胞因子
    • 肿瘤抑制剂
    • 自杀
    • 不足
    • 生长因子
    • 受体
    • 其他的

第 9 章：基因治疗市场 - 按治疗

  • 概述
    • 按疗法分類的细分市场份额分析
    • 体内治疗
    • 离体治疗

第 10 章：基因治疗市场 -按应用

  • 概述
    • 按应用的细分市场占有率分析
    • 肿瘤疾病
    • 罕见疾病
    • 神经系统疾病
    • 其他疾病

第 11 章：基因治疗市场 - 按地理位置

  • 介绍
    • 按地理位置分類的细分市场占有率分析
  • 北美洲
    • 概述
    • 北美基因治疗主要製造商
    • 北美市场规模和预测（按国家）
    • 北美市场规模和预测（按向量类型）
    • 北美市场规模和预测（按基因类型）
    • 北美市场规模和预测（按治疗）
    • 北美市场规模和预测（按应用）
    • 我们
    • 加拿大
  • 欧洲
    • 概述
    • 欧洲基因治疗主要製造商
    • 欧洲市场规模和预测（按国家）
    • 欧洲市场规模和预测（按向量类型）
    • 欧洲市场规模和预测（按基因类型）
    • 欧洲市场规模与预测（按治疗）
    • 欧洲市场规模和预测（按应用）
    • 德国
    • 义大利
    • 英国
    • 法国
    • 俄罗斯
    • 荷兰
    • 瑞典
    • 波兰
    • 欧洲其他地区
  • 亚太地区 (APAC)
    • 概述
    • 亚太地区基因治疗主要製造商
    • 亚太地区市场规模与预测（按国家）
    • 亚太地区市场规模与预测（按向量类型）
    • 亚太地区市场规模和预测（按基因类型）
    • 亚太地区市场规模与预测（按治疗）
    • 亚太地区市场规模与预测（按应用）
    • 印度
    • 中国
    • 日本
    • 韩国
    • 澳洲
    • 泰国
    • 印尼
    • 菲律宾
    • 亚太地区其他地区
  • 拉丁美洲
    • 概述
    • 拉丁美洲基因治疗主要製造商
    • 拉丁美洲市场规模与预测（按国家）
    • 拉丁美洲市场规模与预测（按向量类型）
    • 拉丁美洲市场规模和预测（按基因类型）
    • 拉丁美洲市场规模与预测（按疗法）
    • 拉丁美洲市场规模与预测（按应用）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 拉丁美洲其他地区
  • 中东和非洲
    • 概述
    • 中东和非洲基因治疗主要製造商
    • 中东和非洲市场规模及预测（按国家）
    • 中东和非洲市场规模及预测（按向量类型）
    • 中东和非洲市场规模及预测（按基因类型）
    • 中东和非洲市场规模和预测（按疗法）
    • 中东和非洲市场规模及预测（按应用）
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 以色列
    • 土耳其
    • 阿尔及利亚
    • 埃及
    • MEA 的其余部分

第 12 章：主要供应商分析 - 基因治疗产业

  • 竞争仪表板
  • 公司简介
    • REGENXBIO, Inc.
    • Oxford BioMedica plc
    • Dimension Therapeutics, Inc.
    • Bristol-Myers Squibb Company
    • SANOFI
    • Applied Genetic Technologies Corporation
    • F. Hoffmann-La Roche Ltd
    • Bluebird Bio, Inc.
    • Novartis AG
    • Taxus Cardium Pharmaceuticals Group, Inc. (Gene Biotherapeutics)
    • UniQure NV
    • Shire Plc
    • Cellectis SA
    • Sangamo Therapeutics, Inc
    • Orchard Therapeutics
    • Gilead Lifesciences, Inc.
    • BENITEC BIOPHARMA
    • Sibiono GeneTech Co., Ltd
    • Shanghai Sunway Biotech Co., Ltd.
    • Gensight Biologics SA
    • Transgene
    • Calimmune, Inc.
    • Epeius Biotechnologies Corp.
    • Astellas Pharma Inc.
    • American Gene Technologies
    • BioMarin Pharmaceuticals, Inc.
    • Others

第 13 章：360 度分析师视角

第 14 章：附录

  • 研究方法论
  • 参考
  • 缩写
  • 免责声明
  • 联络我们
Product Code: ANV2021

REPORT HIGHLIGHT

Gene Therapy Market size was valued at USD 8,300 Million in 2022, expanding at a CAGR of 22.3% from 2023 to 2030.

Gene therapy is a technique that modifies a person's genes to treat or cure disease. Currently, gene therapies are being utilized to address specific conditions such as Leber congenital amaurosis, an eye disorder, and spinal muscular atrophy, a muscle disorder. However, extensive research is being conducted to ensure the safety and efficacy of numerous other gene therapies. Additionally, genome editing, a promising technique currently under investigation, holds the potential to treat various disorders in the near future. It is important to note that gene therapy products are regulated by the FDA's Center for Biologics Evaluation and Research (CBER) as they are considered biological products. Another innovative technique known as genome editing, exemplified by CRISPR-Cas9, takes a different approach by utilizing molecular tools to modify the existing DNA within cells, rather than introducing new genetic material.

Gene Therapy Market- Market Dynamics

Increase in the prevalence of chronic disorders such as cancer, rare disease genetic disorders, and others globally anticipated to drive the Gene Therapy market growth.

Gene therapy presents a promising strategy for combating cancer by specifically targeting the underlying genetic abnormalities responsible for its progression. According to the World Health Organization, there were approximately 18.1 million cancer cases worldwide in 2020, with 9.3 million affecting men and 8.8 million affecting women. While gene therapies primarily focus on addressing rare genetic disorders that lack effective traditional treatment options, the National Center for Biotechnology Information estimates that each year, 495,000 infants are born with congenital malformations, 390,000 with G6PD deficiency, 21,400 with Down syndrome, 9,000 with beta-thalassemia, 5,200 with sickle cell disease, and 9,760 with amino acid disorders. By tailoring treatment to an individual's specific genetic profile, gene therapy enables a more personalized approach to healthcare. Moreover, increased investment and funding in gene therapy research and development can create opportunities for market growth. However, the substantial cost associated with gene therapies presents challenges in terms of reimbursement and accessibility.

Gene Therapy Market- Key Insights

As per the analysis shared by our research analyst, the global Gene Therapy market is estimated to grow annually at a CAGR of around 22.3% over the forecast period (2023-2030)

Based on Vector Type segmentation, Non-viral vectors was predicted to show maximum market share in the year 2022

Based on Gene Type segmentation, Antigen was the leading type in 2022

Based on Therapy segmentation, In Vivo Therapy was the leading type in 2022

Based on Application segmentation, Oncological Disorders was the leading type in 2022

On the basis of region, North America was the leading revenue generator in 2022

Gene Therapy Market- Segmentation Analysis:

The Global Gene Therapy Market is segmented based on Vector Type, Gene Type, Therapy, Application, and Region.

The market is divided into three categories based on Vector Type: Viral Vector and Non-Viral Vector. The market is primarily dominated by Non-Viral Vectors. Generally, Non-viral vectors exhibit a superior safety profile compared to viral vectors, thereby minimizing the chances of immune responses or unintended side effects. Moreover, Non-viral vectors possess the capability to accommodate larger DNA payloads, enabling the delivery of more extensive genetic material.

The market is divided into two categories based on Gene Type: Antigen, Cytokine, Tumor Suppressor, Suicide, Deficiency, Growth factors, Receptors and Others. The antigen segment dominates the market. Gene therapy plays a significant role in enhancing the immune system's ability to recognize and attack specific antigens associated with diseases.

The market is divided into three categories based on Therapy: In Vivo Therapy and Ex Vivo Therapy. In Vivo Therapy dominates the market. In Vivo Therapy holds a significant position in the market. Researchers are actively investigating in vivo gene therapy for various diseases, such as genetic disorders, specific forms of cancer, and other medical conditions. The aim is to modify the patient's genetic material to offer therapeutic advantages.

The market is divided into three categories based on Application: Oncological Disorders, Rare Diseases, Neurological Disorders and Other Diseases. The market is primarily dominated by the Oncological Disorders segment. Several gene therapies targeting oncological disorders are currently undergoing clinical trials at different stages. Certain therapies have obtained regulatory approvals for specific indications, whereas others are still in the investigational phases.

Gene Therapy Market- Geographical Insights

Geographically, this market is widespread across North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided based on the countries involved in the business. The North American region is expected to dominate the market's growth due to its highly advanced hospital infrastructure and the increasing demand for cell and gene therapy. North America boasts a robust healthcare ecosystem characterized by collaborations between academia, industry, and healthcare providers. This collaborative environment fosters innovation and expedites the translation of scientific discoveries into clinical applications. According to the American Hospital Association Information Technology, in 2018, 98.3% of hospitals had adopted Electronic Health Records (EHRs), with no differences based on Critical Access Hospital (CAH) status. Additionally, 58.7% and 55.6% of hospitals had adopted advanced Patient Engagement (PE) and Clinical Document Architecture (CDA) functions, respectively. The growing recognition of the potential of cell and gene therapies in treating various diseases, including cancer and genetic disorders, has led to an increasing demand for these therapies. The United States Food and Drug Administration (FDA) has approved four gene therapies for sale in the United States (U.S.) as of December 2022: Luxterna (voretigene neparvovec) approved in 2017, Zolgensma (onasemnogene abeparvovec-xioi) approved in 2019, Tecartus (brexucabtagene autoleucel) approved in 2020, and Hemgenix (etranacogene dezaparvovec) approved in 2022. Although still in its early stages, gene therapy holds the potential to treat and potentially cure diseases that were previously considered untreatable. Europe is projected to be the second-largest gene therapy market in the upcoming years, primarily due to the growing demand for personalized gene-based treatments.

Gene Therapy Market- Competitive Landscape:

The gene therapy market is experiencing significant growth with numerous therapies being developed for various indications. This presents a competitive landscape that requires thorough analysis to identify opportunities and challenges for gene therapy developers. In the pharmaceutical industry, the emergence of cell and gene therapy has brought about innovative treatments, with companies focusing on patents and investing strategically to introduce advanced technologies. These investments not only enhance patent portfolios but also position key players at the forefront of industry advancements. Recent deals highlight the importance of cell and gene therapy in the pharmaceutical sector, with dynamic shifts in strategic partnerships, patents, and job trends. The United States leads in global adoption, with collaborative efforts, transformative patents, and evolving job opportunities shaping the future of innovative advancements. As more gene therapies enter the market, companies must effectively prepare their products and go-to-market strategies to fulfill their promise of transforming patient lives. These companies must launch their products in a way that maximizes patient benefits while ensuring success in the market.

Recent Developments:

In Dec 22, 2021, Novartis announced that it entered into a definitive agreement to acquire all of the outstanding share capital of the UK-based ocular gene therapy company Gyroscope Therapeutics. Geographic atrophy is an advanced form of dry age-related macular degeneration leading to advanced and irreversible idea loss1.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL GENE THERAPY MARKET KEY PLAYERS

  • REGENXBIO, Inc.
  • Oxford BioMedica plc
  • Dimension Therapeutics, Inc.
  • Bristol-Myers Squibb Company
  • SANOFI
  • Applied Genetic Technologies Corporation
  • F. Hoffmann-La Roche Ltd
  • Bluebird Bio, Inc.
  • Novartis AG
  • Taxus Cardium Pharmaceuticals Group, Inc. (Gene Biotherapeutics)
  • UniQure N.V.
  • Shire Plc
  • Cellectis S.A.
  • Sangamo Therapeutics, Inc
  • Orchard Therapeutics
  • Gilead Lifesciences, Inc.
  • BENITEC BIOPHARMA
  • Sibiono GeneTech Co., Ltd
  • Shanghai Sunway Biotech Co., Ltd.
  • Gensight Biologics S.A.
  • Transgene
  • Calimmune, Inc.
  • Epeius Biotechnologies Corp.
  • Astellas Pharma Inc.
  • American Gene Technologies
  • BioMarin Pharmaceuticals, Inc.
  • Others

GLOBAL GENE THERAPY MARKET, BY VECTOR TYPE

  • Viral Vector
  • Non-Viral Vector

GLOBAL GENE THERAPY MARKET, BY GENE TYPE

  • Antigen
  • Cytokine
  • Tumor Suppressor
  • Suicide
  • Deficiency
  • Growth factors
  • Receptors
  • Others

GLOBAL GENE THERAPY MARKET, BY THERAPY

  • In Vivo Therapy
  • Ex Vivo Therapy

GLOBAL GENE THERAPY MARKET, BY APPLICATION

  • Oncological Disorders
  • Rare Diseases
  • Neurological Disorders
  • Other Diseases

GLOBAL GENE THERAPY MARKET, BY REGION

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Gene Therapy Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Gene Therapy Market Snippet by Vector Type
    • 2.1.2. Gene Therapy Market Snippet by Gene Type
    • 2.1.3. Gene Therapy Market Snippet by Therapy
    • 2.1.4. Gene Therapy Market Snippet by Application
    • 2.1.5. Gene Therapy Market Snippet by Country
    • 2.1.6. Gene Therapy Market Snippet by Region
  • 2.2. Competitive Insights

3. Gene Therapy Key Market Trends

  • 3.1. Gene Therapy Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Gene Therapy Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Gene Therapy Market Opportunities
  • 3.4. Gene Therapy Market Future Trends

4. Gene Therapy Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Gene Therapy Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Gene Therapy Market Landscape

  • 6.1. Gene Therapy Market Share Analysis, 2022
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Gene Therapy Market - By Vector Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Vector Type, 2022 & 2030 (%)
    • 7.1.2. Viral Vector
    • 7.1.3. Non-Viral Vector

8. Gene Therapy Market - By Gene Type

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Gene Type, 2022 & 2030 (%)
    • 8.1.2. Antigen
    • 8.1.3. Cytokine
    • 8.1.4. Tumor Suppressor
    • 8.1.5. Suicide
    • 8.1.6. Deficiency
    • 8.1.7. Growth factors
    • 8.1.8. Receptors
    • 8.1.9. Others

9. Gene Therapy Market - By Therapy

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Therapy, 2022 & 2030 (%)
    • 9.1.2. In Vivo Therapy
    • 9.1.3. Ex Vivo Therapy

10. Gene Therapy Market - By Application

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By Application, 2022 & 2030 (%)
    • 10.1.2. Oncological Disorders
    • 10.1.3. Rare Diseases
    • 10.1.4. Neurological Disorders
    • 10.1.5. Other Diseases

11. Gene Therapy Market- By Geography

  • 11.1. Introduction
    • 11.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
  • 11.2. North America
    • 11.2.1. Overview
    • 11.2.2. Gene Therapy Key Manufacturers in North America
    • 11.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 11.2.4. North America Market Size and Forecast, By Vector Type, 2018 - 2030 (US$ Million)
    • 11.2.5. North America Market Size and Forecast, By Gene Type, 2018 - 2030 (US$ Million)
    • 11.2.6. North America Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
    • 11.2.7. North America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.2.8. U.S.
      • 11.2.8.1. Overview
      • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.2.8.3. U.S. Market Size and Forecast, By Vector Type, 2018 - 2030 (US$ Million)
      • 11.2.8.4. U.S. Market Size and Forecast, By Gene Type, 2018 - 2030 (US$ Million)
      • 11.2.8.5. U.S. Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 11.2.8.6. U.S. Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.2.9. Canada
      • 11.2.9.1. Overview
      • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.2.9.3. Canada Market Size and Forecast, By Vector Type, 2018 - 2030 (US$ Million)
      • 11.2.9.4. Canada Market Size and Forecast, By Gene Type, 2018 - 2030 (US$ Million)
      • 11.2.9.5. Canada Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 11.2.9.6. Canada Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 11.3. Europe
    • 11.3.1. Overview
    • 11.3.2. Gene Therapy Key Manufacturers in Europe
    • 11.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 11.3.4. Europe Market Size and Forecast, By Vector Type, 2018 - 2030 (US$ Million)
    • 11.3.5. Europe Market Size and Forecast, By Gene Type, 2018 - 2030 (US$ Million)
    • 11.3.6. Europe Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
    • 11.3.7. Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.3.8. Germany
      • 11.3.8.1. Overview
      • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.8.3. Germany Market Size and Forecast, By Vector Type, 2018 - 2030 (US$ Million)
      • 11.3.8.4. Germany Market Size and Forecast, By Gene Type, 2018 - 2030 (US$ Million)
      • 11.3.8.5. Germany Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 11.3.8.6. Germany Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.3.9. Italy
      • 11.3.9.1. Overview
      • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.9.3. Italy Market Size and Forecast, By Vector Type, 2018 - 2030 (US$ Million)
      • 11.3.9.4. Italy Market Size and Forecast, By Gene Type, 2018 - 2030 (US$ Million)
      • 11.3.9.5. Italy Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 11.3.9.6. Italy Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.3.10. United Kingdom
      • 11.3.10.1. Overview
      • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.10.3. United Kingdom Market Size and Forecast, By Vector Type, 2018 - 2030 (US$ Million)
      • 11.3.10.4. United Kingdom Market Size and Forecast, By Gene Type, 2018 - 2030 (US$ Million)
      • 11.3.10.5. United Kingdom Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 11.3.10.6. United Kingdom Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.3.11. France
      • 11.3.11.1. Overview
      • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.11.3. France Market Size and Forecast, By Vector Type, 2018 - 2030 (US$ Million)
      • 11.3.11.4. France Market Size and Forecast, By Gene Type, 2018 - 2030 (US$ Million)
      • 11.3.11.5. France Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 11.3.11.6. France Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.3.12. Russia
      • 11.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.12.2. Russia Market Size and Forecast, By Vector Type, 2018 - 2030 (US$ Million)
      • 11.3.12.3. Russia Market Size and Forecast, By Gene Type, 2018 - 2030 (US$ Million)
      • 11.3.12.4. Russia Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 11.3.12.5. Russia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.3.13. Netherlands
      • 11.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.13.2. Netherlands Market Size and Forecast, By Vector Type, 2018 - 2030 (US$ Million)
      • 11.3.13.3. Netherlands Market Size and Forecast, By Gene Type, 2018 - 2030 (US$ Million)
      • 11.3.13.4. Netherlands Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 11.3.13.5. Netherlands Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.3.14. Sweden
      • 11.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.14.2. Sweden Market Size and Forecast, By Vector Type, 2018 - 2030 (US$ Million)
      • 11.3.14.3. Sweden Market Size and Forecast, By Gene Type, 2018 - 2030 (US$ Million)
      • 11.3.14.4. Sweden Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 11.3.14.5. Sweden Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.3.15. Poland
      • 11.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.15.2. Poland Market Size and Forecast, By Vector Type, 2018 - 2030 (US$ Million)
      • 11.3.15.3. Poland Market Size and Forecast, By Gene Type, 2018 - 2030 (US$ Million)
      • 11.3.15.4. Poland Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 11.3.15.5. Poland Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.3.16. Rest of Europe
      • 11.3.16.1. Overview
      • 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.16.3. Rest of the Europe Market Size and Forecast, By Vector Type, 2018 - 2030 (US$ Million)
      • 11.3.16.4. Rest of the Europe Market Size and Forecast, By Gene Type, 2018 - 2030 (US$ Million)
      • 11.3.16.5. Rest of the Europe Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 11.3.16.6. Rest of the Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 11.4. Asia Pacific (APAC)
    • 11.4.1. Overview
    • 11.4.2. Gene Therapy Key Manufacturers in Asia Pacific
    • 11.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 11.4.4. Asia Pacific Market Size and Forecast, By Vector Type, 2018 - 2030 (US$ Million)
    • 11.4.5. Asia Pacific Market Size and Forecast, By Gene Type, 2018 - 2030 (US$ Million)
    • 11.4.6. Asia Pacific Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
    • 11.4.7. Asia Pacific Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.4.8. India
      • 11.4.8.1. Overview
      • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.8.3. India Market Size and Forecast, By Vector Type, 2018 - 2030 (US$ Million)
      • 11.4.8.4. India Market Size and Forecast, By Gene Type, 2018 - 2030 (US$ Million)
      • 11.4.8.5. India Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 11.4.8.6. India Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.4.9. China
      • 11.4.9.1. Overview
      • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.9.3. China Market Size and Forecast, By Vector Type, 2018 - 2030 (US$ Million)
      • 11.4.9.4. China Market Size and Forecast, By Gene Type, 2018 - 2030 (US$ Million)
      • 11.4.9.5. China Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 11.4.9.6. China Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.4.10. Japan
      • 11.4.10.1. Overview
      • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.10.3. Japan Market Size and Forecast, By Vector Type, 2018 - 2030 (US$ Million)
      • 11.4.10.4. Japan Market Size and Forecast, By Gene Type, 2018 - 2030 (US$ Million)
      • 11.4.10.5. Japan Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 11.4.10.6. Japan Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.4.11. South Korea
      • 11.4.11.1. Overview
      • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.11.3. South Korea Market Size and Forecast, By Vector Type, 2018 - 2030 (US$ Million)
      • 11.4.11.4. South Korea Market Size and Forecast, By Gene Type, 2018 - 2030 (US$ Million)
      • 11.4.11.5. South Korea Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 11.4.11.6. South Korea Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.4.12. Australia
      • 11.4.12.1. Overview
      • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.12.3. Australia Market Size and Forecast, By Vector Type, 2018 - 2030 (US$ Million)
      • 11.4.12.4. Australia Market Size and Forecast, By Gene Type, 2018 - 2030 (US$ Million)
      • 11.4.12.5. Australia Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 11.4.12.6. Australia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.4.13. Thailand
      • 11.4.13.1. Overview
      • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.13.3. Thailand Market Size and Forecast, By Vector Type, 2018 - 2030 (US$ Million)
      • 11.4.13.4. Thailand Market Size and Forecast, By Gene Type, 2018 - 2030 (US$ Million)
      • 11.4.13.5. Thailand Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 11.4.13.6. Thailand Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.4.14. Indonesia
      • 11.4.14.1. Overview
      • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.14.3. Indonesia Market Size and Forecast, By Vector Type, 2018 - 2030 (US$ Million)
      • 11.4.14.4. Indonesia Market Size and Forecast, By Gene Type, 2018 - 2030 (US$ Million)
      • 11.4.14.5. Indonesia Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 11.4.14.6. Indonesia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.4.15. Philippines
      • 11.4.15.1. Overview
      • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.15.3. Philippines Market Size and Forecast, By Vector Type, 2018 - 2030 (US$ Million)
      • 11.4.15.4. Philippines Market Size and Forecast, By Gene Type, 2018 - 2030 (US$ Million)
      • 11.4.15.5. Philippines Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 11.4.15.6. Philippines Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.4.16. Rest of APAC
      • 11.4.16.1. Overview
      • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.16.3. Rest of APAC Market Size and Forecast, By Vector Type, 2018 - 2030 (US$ Million)
      • 11.4.16.4. Rest of APAC Market Size and Forecast, By Gene Type, 2018 - 2030 (US$ Million)
      • 11.4.16.5. Rest of APAC Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 11.4.16.6. Rest of APAC Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 11.5. Latin America
    • 11.5.1. Overview
    • 11.5.2. Gene Therapy Key Manufacturers in Latin America
    • 11.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 11.5.4. Latin America Market Size and Forecast, By Vector Type, 2018 - 2030 (US$ Million)
    • 11.5.5. Latin America Market Size and Forecast, By Gene Type, 2018 - 2030 (US$ Million)
    • 11.5.6. Latin America Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
    • 11.5.7. Latin America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.5.8. Brazil
      • 11.5.8.1. Overview
      • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.5.8.3. Brazil Market Size and Forecast, By Vector Type, 2018 - 2030 (US$ Million)
      • 11.5.8.4. Brazil Market Size and Forecast, By Gene Type, 2018 - 2030 (US$ Million)
      • 11.5.8.5. Brazil Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 11.5.8.6. Brazil Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.5.9. Mexico
      • 11.5.9.1. Overview
      • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.5.9.3. Mexico Market Size and Forecast, By Vector Type, 2018 - 2030 (US$ Million)
      • 11.5.9.4. Mexico Market Size and Forecast, By Gene Type, 2018 - 2030 (US$ Million)
      • 11.5.9.5. Mexico Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 11.5.9.6. Mexico Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.5.10. Argentina
      • 11.5.10.1. Overview
      • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.5.10.3. Argentina Market Size and Forecast, By Vector Type, 2018 - 2030 (US$ Million)
      • 11.5.10.4. Argentina Market Size and Forecast, By Gene Type, 2018 - 2030 (US$ Million)
      • 11.5.10.5. Argentina Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 11.5.10.6. Argentina Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.5.11. Colombia
      • 11.5.11.1. Overview
      • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.5.11.3. Colombia Market Size and Forecast, By Vector Type, 2018 - 2030 (US$ Million)
      • 11.5.11.4. Colombia Market Size and Forecast, By Gene Type, 2018 - 2030 (US$ Million)
      • 11.5.11.5. Colombia Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 11.5.11.6. Colombia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.5.12. Rest of LATAM
      • 11.5.12.1. Overview
      • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Vector Type, 2018 - 2030 (US$ Million)
      • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Gene Type, 2018 - 2030 (US$ Million)
      • 11.5.12.5. Rest of LATAM Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 11.5.12.6. Rest of LATAM Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 11.6. Middle East and Africa
    • 11.6.1. Overview
    • 11.6.2. Gene Therapy Key Manufacturers in Middle East and Africa
    • 11.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 11.6.4. Middle East and Africa Market Size and Forecast, By Vector Type, 2018 - 2030 (US$ Million)
    • 11.6.5. Middle East and Africa Market Size and Forecast, By Gene Type, 2018 - 2030 (US$ Million)
    • 11.6.6. Middle East and Africa Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
    • 11.6.7. Middle East and Africa Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.6.8. Saudi Arabia
      • 11.6.8.1. Overview
      • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Vector Type, 2018 - 2030 (US$ Million)
      • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Gene Type, 2018 - 2030 (US$ Million)
      • 11.6.8.5. Saudi Arabia Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 11.6.8.6. Saudi Arabia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.6.9. United Arab Emirates
      • 11.6.9.1. Overview
      • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Vector Type, 2018 - 2030 (US$ Million)
      • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Gene Type, 2018 - 2030 (US$ Million)
      • 11.6.9.5. United Arab Emirates Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 11.6.9.6. United Arab Emirates Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.6.10. Israel
      • 11.6.10.1. Overview
      • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.10.3. Israel Market Size and Forecast, By Vector Type, 2018 - 2030 (US$ Million)
      • 11.6.10.4. Israel Market Size and Forecast, By Gene Type, 2018 - 2030 (US$ Million)
      • 11.6.10.5. Israel Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 11.6.10.6. Israel Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.6.11. Turkey
      • 11.6.11.1. Overview
      • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.11.3. Turkey Market Size and Forecast, By Vector Type, 2018 - 2030 (US$ Million)
      • 11.6.11.4. Turkey Market Size and Forecast, By Gene Type, 2018 - 2030 (US$ Million)
      • 11.6.11.5. Turkey Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 11.6.11.6. Turkey Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.6.12. Algeria
      • 11.6.12.1. Overview
      • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.12.3. Algeria Market Size and Forecast, By Vector Type, 2018 - 2030 (US$ Million)
      • 11.6.12.4. Algeria Market Size and Forecast, By Gene Type, 2018 - 2030 (US$ Million)
      • 11.6.12.5. Algeria Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 11.6.12.6. Algeria Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.6.13. Egypt
      • 11.6.13.1. Overview
      • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.13.3. Egypt Market Size and Forecast, By Vector Type, 2018 - 2030 (US$ Million)
      • 11.6.13.4. Egypt Market Size and Forecast, By Gene Type, 2018 - 2030 (US$ Million)
      • 11.6.13.5. Egypt Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 11.6.13.6. Egypt Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.6.14. Rest of MEA
      • 11.6.14.1. Overview
      • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.14.3. Rest of MEA Market Size and Forecast, By Vector Type, 2018 - 2030 (US$ Million)
      • 11.6.14.4. Rest of MEA Market Size and Forecast, By Gene Type, 2018 - 2030 (US$ Million)
      • 11.6.14.5. Rest of MEA Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 11.6.14.6. Rest of MEA Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)

12. Key Vendor Analysis- Gene Therapy Industry

  • 12.1. Competitive Dashboard
  • 12.2. Company Profiles
    • 12.2.1. REGENXBIO, Inc.
    • 12.2.2. Oxford BioMedica plc
    • 12.2.3. Dimension Therapeutics, Inc.
    • 12.2.4. Bristol-Myers Squibb Company
    • 12.2.5. SANOFI
    • 12.2.6. Applied Genetic Technologies Corporation
    • 12.2.7. F. Hoffmann-La Roche Ltd
    • 12.2.8. Bluebird Bio, Inc.
    • 12.2.9. Novartis AG
    • 12.2.10. Taxus Cardium Pharmaceuticals Group, Inc. (Gene Biotherapeutics)
    • 12.2.11. UniQure N.V.
    • 12.2.12. Shire Plc
    • 12.2.13. Cellectis S.A.
    • 12.2.14. Sangamo Therapeutics, Inc
    • 12.2.15. Orchard Therapeutics
    • 12.2.16. Gilead Lifesciences, Inc.
    • 12.2.17. BENITEC BIOPHARMA
    • 12.2.18. Sibiono GeneTech Co., Ltd
    • 12.2.19. Shanghai Sunway Biotech Co., Ltd.
    • 12.2.20. Gensight Biologics S.A.
    • 12.2.21. Transgene
    • 12.2.22. Calimmune, Inc.
    • 12.2.23. Epeius Biotechnologies Corp.
    • 12.2.24. Astellas Pharma Inc.
    • 12.2.25. American Gene Technologies
    • 12.2.26. BioMarin Pharmaceuticals, Inc.
    • 12.2.27. Others

13. 360 Degree Analyst View

14. Appendix

  • 14.1. Research Methodology
  • 14.2. References
  • 14.3. Abbreviations
  • 14.4. Disclaimer
  • 14.5. Contact Us

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Gene Therapy Market: Vector Type Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Vector Type
  • TABLE Global Gene Therapy Market, by Vector Type 2018-2030 (USD Million)
  • TABLE Gene Therapy Market: Gene Type Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Gene Type
  • TABLE Global Gene Therapy Market, by Gene Type 2018-2030 (USD Million)
  • TABLE Gene Therapy Market: Therapy Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Therapy
  • TABLE Global Gene Therapy Market, by Therapy 2018-2030 (USD Million)
  • TABLE Gene Therapy Market: Application Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Application
  • TABLE Global Gene Therapy Market, by Application 2018-2030 (USD Million)
  • TABLE Gene Therapy Market: Regional snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Gene Therapy Market, by Region 2018-2030 (USD Million)
  • TABLE North America Gene Therapy Market, by Country, 2018-2030 (USD Million)
  • TABLE North America Gene Therapy Market, by Vector Type, 2018-2030 (USD Million)
  • TABLE North America Gene Therapy Market, by Gene Type, 2018-2030 (USD Million)
  • TABLE North America Gene Therapy Market, by Therapy, 2018-2030 (USD Million)
  • TABLE North America Gene Therapy Market, by Application, 2018-2030 (USD Million)
  • TABLE Europe Gene Therapy Market, by Country, 2018-2030 (USD Million)
  • TABLE Europe Gene Therapy Market, by Vector Type, 2018-2030 (USD Million)
  • TABLE Europe Gene Therapy Market, by Gene Type, 2018-2030 (USD Million)
  • TABLE Europe Gene Therapy Market, by Therapy, 2018-2030 (USD Million)
  • TABLE Europe Gene Therapy Market, by Application, 2018-2030 (USD Million)
  • TABLE Asia Pacific Gene Therapy Market, by Country, 2018-2030 (USD Million)
  • TABLE Asia Pacific Gene Therapy Market, by Vector Type, 2018-2030 (USD Million)
  • TABLE Asia Pacific Gene Therapy Market, by Gene Type, 2018-2030 (USD Million)
  • TABLE Asia Pacific Gene Therapy Market, by Therapy, 2018-2030 (USD Million)
  • TABLE Asia Pacific Gene Therapy Market, by Application, 2018-2030 (USD Million)
  • TABLE Latin America Gene Therapy Market, by Country, 2018-2030 (USD Million)
  • TABLE Latin America Gene Therapy Market, by Vector Type, 2018-2030 (USD Million)
  • TABLE Latin America Gene Therapy Market, by Gene Type, 2018-2030 (USD Million)
  • TABLE Latin America Gene Therapy Market, by Therapy, 2018-2030 (USD Million)
  • TABLE Latin America Gene Therapy Market, by Application, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Gene Therapy Market, by Country, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Gene Therapy Market, by Vector Type, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Gene Therapy Market, by Gene Type, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Gene Therapy Market, by Therapy, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Gene Therapy Market, by Application, 2018-2030 (USD Million)

List of Figures

  • FIGURE Gene Therapy Market Segmentation
  • FIGURE Market research methodology
  • FIGURE Value chain analysis
  • FIGURE Porter's Five Forces Analysis
  • FIGURE Market Attractiveness Analysis
  • FIGURE COVID-19 Impact Analysis
  • FIGURE Pre & Post COVID-19 Impact Comparision Study
  • FIGURE Competitive Landscape; Key company market share analysis, 2022
  • FIGURE Vector Type segment market share analysis, 2022 & 2030
  • FIGURE Vector Type segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Gene Type segment market share analysis, 2022 & 2030
  • FIGURE Gene Type segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Therapy segment market share analysis, 2022 & 2030
  • FIGURE Therapy segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Application segment market share analysis, 2022 & 2030
  • FIGURE Application segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Regional segment market share analysis, 2022 & 2030
  • FIGURE Regional segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE North America Gene Therapy Market share and leading players, 2022
  • FIGURE Europe Gene Therapy Market share and leading players, 2022
  • FIGURE Asia Pacific Gene Therapy Market share and leading players, 2022
  • FIGURE Latin America Gene Therapy Market share and leading players, 2022
  • FIGURE Middle East and Africa Gene Therapy Market share and leading players, 2022
  • FIGURE North America market share analysis by country, 2022
  • FIGURE U.S. Gene Therapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Canada Gene Therapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Europe Gene Therapy Market share analysis by country, 2022
  • FIGURE Germany Gene Therapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Spain Gene Therapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Italy Gene Therapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE France Gene Therapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE UK Gene Therapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Russia Gene Therapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Netherlands Gene Therapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Sweden Gene Therapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Poland Gene Therapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of the Europe Gene Therapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Asia Pacific Gene Therapy Market share analysis by country, 2022
  • FIGURE India Gene Therapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE China Gene Therapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Japan Gene Therapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE South Korea Gene Therapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Australia Gene Therapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Thailand Gene Therapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Indonesia Gene Therapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Phillipines Gene Therapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of APAC Gene Therapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America Gene Therapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America Gene Therapy Market share analysis by country, 2022
  • FIGURE Brazil Gene Therapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Mexico Gene Therapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Argentina Gene Therapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Colombia Gene Therapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of LATAM Gene Therapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa Gene Therapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa Gene Therapy Market share analysis by country, 2022
  • FIGURE Saudi Arabia Gene Therapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE United Arab Emirates Gene Therapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Israel Gene Therapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Turkey Gene Therapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Algeria Gene Therapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Egypt Gene Therapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of MEA Gene Therapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)